Epigenomics AG (Frankfurt:ECX) (Other OTC:EPGNF), a molecular diagnostics company developing tests based on DNA methylation, announced today an 18-month extension of its collaboration with Roche Diagnostics on blood screening products for various cancers until September 30, 2007.
